High Risk Cytogenetic Abnormalities Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients Received Autologous Hematopoietic Cell Transplantation

被引：0

作者：

Geng, Chuanying ^{[1
]}

Lu, Jing ^{[2
,27
]}

Li, Xiaozhe ^{[3
]}

Li, Qiang ^{[4
]}

Li, Na ^{[4
]}

Tian, Weiwei ^{[5
]}

Zhao, Jie ^{[6
]}

Yang, Guangzhong

Ma, Yanping ^{[7
]}

Qin, Xiaoqi

Jia, Jing ^{[1
]}

Zhou, Huixing ^{[9
]}

Hi, Lintao ^{[10
]}

Wang, Chenchen ^{[11
]}

Sun, Ying ^{[12
]}

Liu, Xiantao ^{[8
,13
]}

Jian, Yuan ^{[14
]}

Wang, Qingming ^{[15
]}

Wan, Haixiang ^{[16
]}

Zhang, Jinqiao ^{[17
]}

Liu, Han ^{[18
]}

Geng, Hui ^{[19
]}

Ma, Xiaojing ^{[19
]}

Liang, Yunxia ^{[20
]}

Hu, Rui ^{[20
]}

Gao, Da ^{[21
]}

Han, Donghai ^{[21
]}

Liu, Haisheng ^{[22
]}

Ma, Guangyu ^{[22
]}

Zhang, Zhihua ^{[23
]}

Wang, Wei ^{[23
]}

Minxia, Shi ^{[24
]}

Nie, Bo ^{[25
]}

Hong, Zhang ^{[26
]}

Li, Jie ^{[35
]}

Jie, Guitao ^{[28
]}

Fan, Meiying ^{[28
]}

Song, Qinglin ^{[29
]}

Li, Wenyong ^{[29
]}

Xi, Zhenfan ^{[30
]}

Gao, Guorong ^{[31
]}

Liu, Jie ^{[32
]}

Li, Zhihua ^{[33
]}

Xue, Hua ^{[34
]}

Guo, Huimei ^{[34
]}

Li, Jie ^{[35
]}

Gao, Xiaohan ^{[36
]}

Su, Guo-Hong ^{[37
]}

Shen, Jie ^{[38
]}

Jin, Aron ^{[39
]}

机构：

[1] Beijing Chao Yang Hosp, Beijing, Peoples R China

[2] Naval Med Univ, Shanghai Changzheng Hosp, Myeloma & Lymphoma Ctr, Dept Hematol, Shanghai, Peoples R China

[3] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China

[4] Liaocheng Peoples Hosp, Liaocheng City, Peoples R China

[5] Third Hosp Shanxi Med Univ, Shanxi Bethune Hosp, Shanxi Acad Med Sci Tongji Shanxi Hosp, Hosp 3,Dept Hematol,Shanxi Acad Med Sci, Taiyuan, Shanxi, Peoples R China

[6] Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Hosp 3, Taiyuan, Peoples R China

[7] Second Hosp Shanxi Med Univ, Dept Hematol, Taiyuan, Peoples R China

[8] Shanxi Med Univ, Taiyuan, Peoples R China

[9] Capital Med Univ, Beijing Chao Yang Hosp, Beijing, Peoples R China

[10] Jilin Univ, Dept Hematol & Oncol, China Japan Union Hosp, Changchun, Peoples R China

[11] Jilin Univ, China Japan Union Hosp, China Japan Union Hosp, Changchun, Peoples R China

[12] Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China

[13] Chifeng Municipal Hosp, Chifeng City, Peoples R China

[14] Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China

[15] Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China

[16] Nanchang Univ, Affiliated Hosp 2, Jiangxi Med Coll, Nanchang City 330006, Jiangxi, Peoples R China

[17] Third Hosp Hebei Med Univ, Dept Orthoped, Shijiazhuang, Hebei, Peoples R China

[18] Third Hosp Hebei Med Univ, Shijiazhuang, Hebei, Peoples R China

[19] Qinghai Univ, Affiliated Hosp, Xining, Peoples R China

[20] Yuncheng Cent Hosp, Yuncheng, Peoples R China

[21] Inner Mongolia Med Univ, Affiliated Hosp, Hohhot, Peoples R China

[22] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China

[23] Chengde Med Univ, Affiliated Hosp, Chengde, Peoples R China

[24] Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China

[25] Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China

[26] Second Affiliated Hosp Shandong First Med Univ, Pediat Intens Care Unit, Tai An 271000, Shandong, Peoples R China

[27] Shandong First Med Univ, Affiliated Hosp 2, Taiyuan, Peoples R China

[28] Linyi Cent Hosp, Linyi, Peoples R China

[29] JiaoZuo Peoples Hosp, Jiaozuo, Henan, Peoples R China

[30] Linfen Peoples Hosp, Dept Hematol, Linfen, Peoples R China

[31] Linfen Peoples Hosp, Linfen, Peoples R China

[32] Washington Univ, Sch Med St Louis, Dept Med, Div Oncol, St Louis, MO USA

[33] Sinopharm Tongmei Gen Hosp, Datong, Peoples R China

[34] Hebei Univ, Affiliated Hosp, Baoding, Peoples R China

[35] Hebei Prov Peoples Hosp, Shijiazhuang, Peoples R China

[36] Hebei Gen Hosp, Shijiazhuang, Peoples R China

[37] Cangzhou Cent Hosp, Cangzhou, Peoples R China

[38] Cangzhou Ctr Hosp, Cangzhou, Peoples R China

[39] Inner Mongolia Autonomous Reg Peoples Hosp, Hohhot City, Peoples R China

[40] Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China

[41] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China

[42] Shanghai Changzheng Hosp, Myeloma & Lymphoma Ctr, Dept Hematol, Shanghai, Peoples R China

[43] Capital Med Univ, Beijing Chao Yang Hosp, Dept Hematol, Beijing, Peoples R China

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-205155

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：6925 / 6926

页数：2

共 50 条

[1] PROGNOSTIC IMPLICATIONS OF MULTIPLE CYTOGENETIC HIGH-RISK ABNORMALITIES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
Binder, M.
Rajkumar, S. V.
Ketterling, R. P.
Dispenzieri, A.
Lacy, M. Q.
Gertz, M. A.
Buadi, F. K.
Hayman, S. R.
Hwa, Y. L.
Zeldenrust, S. R.
Lust, J. A.
Russell, S. J.
Leung, N.
Kapoor, P.
Go, R. S.
Gonsalves, W. I.
Kyle, R. A.
Kumar, S. K.
HAEMATOLOGICA, 2017, 102 : 107 - 107
[2] Prognostic Implications of Multiple Cytogenetic High-Risk Abnormalities in Patients with Newly Diagnosed Multiple Myeloma
Binder, Moritz
Rajkumar, S. Vincent
Ketterling, Rhett P.
Dispenzieri, Angela
Lacy, Martha Q.
Gertz, Morie A.
Buadi, Francis K.
Hayman, Suzanne R.
Hwa, Yi L.
Zeldenrust, Steven R.
Lust, John A.
Russell, Stephen J.
Leung, Nelson
Kapoor, Prashant
Go, Ronald S.
Gonsalves, Wilson I.
Kyle, Robert A.
Kumar, Shaji
BLOOD, 2016, 128 (22)
[3] Impact of autologous stem cell transplantation (ASCT) on progression free survival (PFS) in newly diagnosed multiple myeloma patients (NDMM) with high risk cytogenetic abnormalities
Guman, Tomas
Sykora, Jan
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2024, 125 (01): : 9 - 11
[4] Prognostic Significance of Blood Transfusion in Newly Diagnosed Multiple Myeloma Patients without Autologous Hematopoietic Stem Cell Transplantation
Fan, Liping
Fu, Danhui
Zhang, Jinping
Huang, Haobo
Wang, Qingqing
Ye, Yamei
Xie, Qianling
BIOMED RESEARCH INTERNATIONAL, 2017, 2017
[5] Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
Binder, M.
Rajkumar, S. V.
Ketterling, R. P.
Greipp, P. T.
Dispenzieri, A.
Lacy, M. Q.
Gertz, M. A.
Buadi, F. K.
Hayman, S. R.
Hwa, Y. L.
Zeldenrust, S. R.
Lust, J. A.
Russell, S. J.
Leung, N.
Kapoor, P.
Go, R. S.
Gonsalves, W. I.
Kyle, R. A.
Kumar, S. K.
BLOOD CANCER JOURNAL, 2017, 7 : e600 - e600
[6] Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
M Binder
S V Rajkumar
R P Ketterling
P T Greipp
A Dispenzieri
M Q Lacy
M A Gertz
F K Buadi
S R Hayman
Y L Hwa
S R Zeldenrust
J A Lust
S J Russell
N Leung
P Kapoor
R S Go
W I Gonsalves
R A Kyle
S K Kumar
Blood Cancer Journal, 2017, 7 : e600 - e600
[7] Double Autologous Stem Cell Transplantation Followed by Maintenance Therapy Conquers the Adverse Cytogenetic Abnormalities in Newly Diagnosed Multiple Myeloma Patients
Motomura, Yotaro
Miwa, Akiyoshi
Hagiwara, Shotaro
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E136 - E136
[8] Impact of Autologous Hematopoietic Stem Cell Transplantation on Newly Diagnosed Multiple Myeloma with Different Cytogenetic Profiles: A Brazilian Unicentric Cohort
Cordeiro, Maria Gabriella
Velloso, Elvira D. R. P.
Leal, Aline de Medeiros
Santos, Joaquim Gasparini
Otuyama, Leonardo
Ramos, Evelin
Seguro, Fernanda Salles
Atanasio, Marcelo Junqueira
Pereira, Thales D. M.
Rocha, Vanderson
Martinez, Gracia Aparecida
BLOOD, 2024, 144 : 6938 - 6939
[9] Daratumumab Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Ma, Panelyi
Xiao, Xiubin
Yuan, Shunzong
Chen, Xilin
Zhao, Shihua
Cheng, Nana
Lu, Yun
Chen, Junli
Wang, Yueqi
Huang, Wenrong
BLOOD, 2023, 142
[10] Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma
Merz, Maximilian
Jauch, Anna
Hielscher, Thomas
Bochtler, Tilmann
Schoenland, Stefan Olaf
Seckinger, Anja
Hose, Dirk
Bertsch, Uta
Neben, Kai
Raab, Marc Steffen
Hillengass, Jens
Salwender, Hans
Blau, Igor Wolfgang
Lindemann, Hans-Walter
Schmidt-Wolf, Ingo G. H.
Scheid, Christof
Haenel, Mathias
Weisel, Katja C.
Goldschmidt, Hartmut
BLOOD ADVANCES, 2018, 2 (01) : 1 - 9

← 1 2 3 4 5 →